Problem statement: Answer the MCQ question.
Question: Which drug exhibits a 21.265% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a) O=C(NNc1nc(-c2ccc(F)cc2)cs1)c1ccccc1
b) COc1ccc(CN(C)C(C)C(=O)Nc2ccc(S(=O)(=O)N3CCOCC3)cc2)c(OC)c1
c) CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
d) COc1cccc(C2(O)C(=O)Nc3ccccc32)c1
Answer: c. CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
CN1CCN(CCC(=O)N/N=C/c2ccccn2)CC1
3-(4-methylpiperazin-1-yl)-N-[(E)-pyridin-2-ylmethylideneamino]propanamide